Loading
Latest filing published 21 Mar 2022 for Bluejay Diagnostics, Inc., €2,629.
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Gordon Winston Kinder in Bluejay Diagnostics, Inc., where the filings describe the role as finance chief. In total, 4 filings cover trades dated from 14 March 2022 to 17 March 2022.
Purchases make up the whole of the open-market record (4 purchases, €17k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €3,639. 1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 21 March 2022 came the latest disclosure, an open-market purchase for €2,629 in Bluejay Diagnostics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations